Press Releases
Samsung Biologics Presents Virtually at Annual Biologics Manufacturing Asia
7th Annual Biologics Manufacturing Asia 2020
WEBINAR SESSIONS-
A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell CUlture Process
July 7, 11:40 ~ 12:05
Yongho Ahn - VP and Head of CDO R&D Team
-
Application of Large Scale N-1 Bioreactor Perfusion
July 7, 14:20 ~ 14:45
SeungSun Lee - Associate Director, MSAT USP
Samsung Biologics will be virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July. As the largest and only bioprocess business and technology convention in the Asia-Pacific, more than 500 biomanufacturing stakeholders from the industry will be attending this year.
The convention will focus on three main agendas: Cell therapy manufacutring and supply chain, Bio-analytics, Bio-manufacturing.
There will be 2 speakers from Samsung Biologics, presenting at two different live stream sessions. VP Yongho Ahn, Head of CDO R&D Team will discuss studies on "A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell Culture Process" on July 7th at 11:40AM. SeungSun Lee, Director of DS USP will also present on July 7th at 14:20PM to talk about "Application of Large Scale N-1 Bioreactor Perfusion". These sessions will last 25minutes each.
To learn more, join our live stream sessions at the 7th Annual Biologics Manufacturing Asia.
7th Annual Biologics Manufacturing Asia 2020
WEBINAR SESSIONS-
A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell CUlture Process
July 7, 11:40 ~ 12:05
Yongho Ahn - VP and Head of CDO R&D Team
-
Application of Large Scale N-1 Bioreactor Perfusion
July 7, 14:20 ~ 14:45
SeungSun Lee - Associate Director, MSAT USP
Samsung Biologics will be virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July. As the largest and only bioprocess business and technology convention in the Asia-Pacific, more than 500 biomanufacturing stakeholders from the industry will be attending this year.
The convention will focus on three main agendas: Cell therapy manufacutring and supply chain, Bio-analytics, Bio-manufacturing.
There will be 2 speakers from Samsung Biologics, presenting at two different live stream sessions. VP Yongho Ahn, Head of CDO R&D Team will discuss studies on "A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell Culture Process" on July 7th at 11:40AM. SeungSun Lee, Director of DS USP will also present on July 7th at 14:20PM to talk about "Application of Large Scale N-1 Bioreactor Perfusion". These sessions will last 25minutes each.
To learn more, join our live stream sessions at the 7th Annual Biologics Manufacturing Asia.